Solventum Corporation reaffirmed earnings guidance for its full-year 2024. For the period, Company expects Organic revenue growth of -2% to 0%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
53.32 USD | -2.40% | -5.70% | 0.00% |
07/06 | Solventum Cautions Stockholders About TRC Capital's Mini-Tender Offer | MT |
30/05 | Goldman Sachs Initiates Solventum With Sell Rating, $54 Price Target | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 9.44B | |
+25.85% | 87.86B | |
-22.73% | 76.69B | |
+3.24% | 26.86B | |
+2.00% | 17.76B | |
-0.42% | 15.22B | |
+72.40% | 13.56B | |
+81.96% | 13.37B | |
-24.56% | 13.01B | |
+25.01% | 12.7B |
- Stock Market
- Equities
- SOLV Stock
- News Solventum Corporation
- Solventum Corporation Reaffirms Earnings Guidance for Its Full-Year 2024